参考文献

[1]Surawicz TS,Davis F,Freels S,Laws ER Jr and Menck HR.Brain tumor survival:results from the National Cancer Data Base.J Neurooncol 1998;40:151～160.
[2]Shapiro WR,Shapiro JR,Walker RW.Central nervous system.in:Abeloff MD,Armitage JO,Lichter AS,Niederhuber JE.eds.,Clinical Oncology, 2nd ed.,Harcourt Asia :Churchill Livingstone.2001:1103～1192.
[3]吴念曾.脑胶质瘤的现代治疗.处方药，2003
[4]吴念曾 王天路 .瘤床局部免疫疗法治疗恶性脑胶质瘤：7年随访结果.解放军医学杂志2003
[5]Morford LA,Elliott LH,Carlson SL,Brooks WH,and Roszman TL.T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors.J Immunol 1997;159:4415～4425.
[6]Black KL,Chen K,Becker DP, and Merrill JE.Inflammatory leukocytes associated with increased immonosuppression by glioblastome.J Neurosurg 1992;77:120～126.
[7]Bullard DE,Gillespie GY,Mahaley MS,et al.Immunobiology of human gliomas.Semin Oncol 1986;13:94～109.
[8]Wood GW,Morantz RA.Depressed T-lymphocyte function in brain tumor patients-monocytes as suppressor factor.J Neurosurg 1983;1:87～95.
[9]Warren. RP,McCall CA,Urban RW.Augmentation of natural killer cell activity by lmuvert:A biological response modifier derived from Serratia marcescens.Mol Biother 1989:1:145～151.
[10]Ascensao J,Mittelman A,Penichet KO,et al.Activated natural killer (NK) cell activaty in patients with advanced cancer treated with lmuvert.Proc Am Assoc Canc Res 1987;28:368(abst).
[11]McCall C,Weimer L,Campbell P,et al.Macrophage activation induced by a biological response modifier derived from Serratia marcescens.J Cell Biochem 1988:12E:175.
[12]Cunningham-Rundles S,Pearson FC.lmuvert activation of natural killer cell cytotoxocity and interferon gamma production of CD 16 triggering.J Immunopharmacol 1990;12:589～598.
[13]Shapiro WR,Voorhies RM,Hiesiger EM,et al.Pharmacokinetics of tumor cell exposure to [14C]methotraxate after intracarotid administration without and with hyperosmotic opening of the blood-brain and bood-tumor barriers in rate brain tumors:a quantitative autoradiographic study.Cancer Res 1988;48:694.
[14]Neuwelt EA,Howieson J,Frenkel EP, et al.Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma.Neurosurgry 1986;19:573.
[15]Proescholdt MA, Merrill MJ, Ikejiri B, et al.Site-specific immune response to implanted gliomas.J Neurosurg 2001;95:1012～1019.
[16]Allen PJ, D’Angelica M, Hodyl C, et al. The effects of hepatic cryosurgery on tumor growth in the liver. Am Surg Res 1998; 77:132～136.
[17]Joosten JJA,v Muijen GNP,Wobbes Th and Ruers TJM.In vivo destruction of tumor tissue by cryoablation can induce inhibition of secondary tumor growth:An experimental study.Cryobiopsy 2001;41:49～58
[18]Urano M,Tanaka C,Sugiyama Y,et al.Antitumor effects of residual tumor after cryoablation:the combined effect of residual tumor and a protein-bound polysaccharide on multiple liver metastases in a murine model.Cryobiology 2003;45:238～245
[19]Sabel MS. Nehs MA, Su G, et al. Immunologic response to cryoablation of breast cancer. Breast Cancer Res Treat 2005;90:97～104